Timothy M. Mayleben, Director at Loxo Oncology, Inc. (LOXO), sold 10,000 shares at $80.49 ($805K) on 2017-12-20, disclosed to the SEC on 2017-12-22.
Open-market sale of $805k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ESPR | BUY | 2019-11-08 | $370K | — | Filing → |
| ESPR | BUY | 2019-09-06 | $259K | — | Filing → |
| ESPR | BUY | 2019-08-02 | $198K | — | Filing → |